Background/Aims: Even though delayed ischemic preconditioning (DIPC) has been reported to produce renal protection, the underlying mechanism remains poorly understood. We ischemia-reperfusion attenuated renal injury. Kidney dendritic cells (DCs) are abundant in the renal tubulointerstitium and, depending on their status, can induce immune activation or tolerance. The aim of the present study was to investigate the role of DCs in IPC of the kidney. Methods: Mouse kidneys were challenged by transient brief episodes of sublethal ischemia the function of mature DCs in the renoprotective effect of IPC on renal ischemia-reperfusion injury, the A2 adenosine receptor (A2AR) antagonist SCH58261 was administered to stimulate DC maturation prior to assessment of renal functional and histological injury and the 
the function of mature DCs in the renoprotective effect of IPC on renal ischemia-reperfusion injury, the A2 adenosine receptor (A2AR) antagonist SCH58261 was administered to stimulate DC maturation prior to assessment of renal functional and histological injury and the Results: Compared with sham-operated animals, preconditioned mice had a reduced injury with less CD11c 
Introduction
Acute kidney injury (AKI) is a common critical illness with a high incidence and high risk of mortality [1] . In 2015, AKI occurred in approximately 13.3 million people, and AKI itself contributes to approximately 1.7 million deaths per year [2] . Among patients who survive, 50% develop chronic kidney disease, and 8.1% of these patients progress to end-stage renal disease and require dialysis or transplantation, resulting in a heavy social burden. However, there are no effective therapies available for the prevention of AKI onset or progression [3] . Therefore, there is an urgent need to identify methods to prevent and control AKI.
Ischemic preconditioning (IPC) refers to transient brief episodes of sublethal ischemia before a subsequent prolonged ischemia, which has been shown to increase organ resistance to ischemic injury (ischemic tolerance). IPC represents an endogenous adaptive response that provides local protection against subsequent ischemia/reperfusion (I/R) injury (IRI).
tissues including the heart, brain, liver and kidney [4] [5] [6] [7] . According to the time window of protection, IPC has been divided into acute IPC (occurring immediately and lasting for 1-2 hours) and delayed IPC (DIPC, occurring 24-48 hours after the IPC stimulus and lasting for several days even weeks) [8, 9] . Both acute IPC and DIPC are protective, however, a metaanalysis of animal studies showed that DIPC is more effective than acute IPC in reducing renal IRI [10] . Our previous study also demonstrated that IPC could reduce renal IRI when conducted 4 days before index ischemia [7, 11] . However, the underlying mechanisms remain elusive.
[12]. Dendritic cells (DCs) are a major component of immunocytes in the kidney and are key initiators and effectors of the innate immune system, acting as immune sentinels and antigen-presenting cells to bridge innate and adaptive immunity [13] . DCs are important for the induction of both immune tolerance and activation. Immature DCs induce tolerance [14, 15] . It has been reported that spleen DCs mediate immune suppression, which plays an important role in tolerance induction in renal DIPC [16] . Thus, we hypothesized that renal DIPC induces changes to both renal and splenic DCs phenotypes, and these changes might be important in mediating the renal protective effect.
The current studies were undertaken to determine the role of DCs in DIPC of the kidney. We compared the renal and splenic immunophenotypes, including the percentage of leukocytes (CD45 , in IPC+I/R with a those in the sham+I/R group. We an immune-regulation mechanism of renal DIPC, we used the A2AR antagonist SCH58261 to inhibit DC maturation. Our results showed that DIPC protects the kidney from IRI by increasing the renal and splenic F4/80 -DC subset with reduced maturity and stimulating DC maturation by SCH58261 attenuated the renal protective effect of DIPC. Thus, we concluded that DIPC of the kidney provides local and systemic immunosuppression by inhibiting DC maturation and hence mediating the renal protective. Further studies identifying the precise immunologic mechanisms of DIPC may promote the development of various strategies in the treatment of AKI. 
Materials and Methods

Animals
of Fudan University, Shanghai, China) and housed in acrylic cages with shredded corn cob bedding in an ad libitum, according to standard protocols for animal care. The procedures used were approved by the
Mouse models of delayed renal IPC and I/R
The animals were randomly divided into the following 3 groups: sham+sham, IPC+sham and IPC+I/R. IPC was performed as described previously [7] . xylazine (15 mg/kg) and ketamine (120 mg/kg) via intraperitoneal injection, bilateral renal pedicles were moistened gauze. Sham mice underwent the same surgical procedures, except that the renal pedicles were not clamped. Four days after IPC or sham surgeries, mice were subjected to the I/R operation (30-min occlusion of bilateral renal pedicles or sham operation followed by reperfusion for 24 h)[17] after which the kidney or spleen were harvested for the following experiment.
For administration of the A2AR antagonist SCH58261, animals were randomly divided into the following 4 groups: DMSO+IPC+I/R, SCH(1 mg)+IPC+I/R, SCH(2 mg)+IPC+I/R, or SCH(5 mg)+IPC+I/R. Accordingly, different does of SCH58261 (1, 2 or 5 mg/kg body weight) or DMSO (vehicle control) were injected intraperitoneally 30 min before I/R operation.
Preparation of Single-Cell Suspensions from Kidney and Spleen
Single cell suspensions of kidney and spleen cells were prepared as described previously [9] . renal tissue was minced into small pieces, followed by digestion and disruption in a 5-ml DMEM mixture min. The resulting pellet was incubated in red blood cell lysis buffer to remove red blood cells.
Flow cytometry
To measure the abundance and maturity of dendritic cells in kidney and spleen samples, single cell CD45 (PE-CY5.5), CD11c (PE), Anti-F 4/80 analysed using FlowJo 10.0 software.
Histopathological Examinations and Immunohistochemical Staining
with a Haematoxylin-Eosin (HE) staining Kit or a CD11c antibody. For HE staining, histologic injury scores were evaluated under light microscopy by a pathologist blinded to the origin of the preparation and determined using a previously described scoring system. Injury was scored according to the percentage 75% (3), and very severe: more than 75% (4). Immunohistochemical staining was performed as described previously [18] . light microscopy. The IOD (integrated optical density) values of positively stained cells were calculated in six representative sections from each animal in a blinded manner and using ImageJ software. a sodium dodecyl sulphate-polyacrylamide gel and transferred to a PVDF membrane. The membrane was blocked with 5% nonfat milk and incubated with the primary antibodies against CCR-7 (1:1000) and GAPDH using a chemiluminescent Horseradish Peroxidase Substrate. The results were normalized to GAPDH.
Analysis of Plasma Creatinine
Blood samples were obtained via cardiac puncture at the indicated times. Plasma creatinine was measured using the improved Jaffe method (Quantichrom creatinine Assay Kit, BioAssay Systems, Hayward, CA) [20] .
Enzyme-Linked Immunosorbent Assay
Kidney tissues were homogenized in PBS and centrifuged to obtain supernatants. Supernatant protein concentrations were measured using a BCA protein assay kit and adjusted to 2×10 
Statistics
Results
Delayed Ischemic Preconditioning Attenuated the Renal Ischemia-Reperfusion Injury Functionally and Histologically
The delayed kidney ischemic preconditioning strategy was performed as shown in Fig. 1A . I/R-induced tubular injury was characterized by tubular cell necrosis, dilation of tubules, and cast formation in the outer medulla. As expected, delayed kidney ischemic from preconditioned ischemic animals showed less tubular injury compared with shamtreated animals (Fig. 1C) .
Delayed Ischemic Preconditioning Suppressed Renal Immune Reaction
To examine whether DIPC induced renoprotection is mediated by their immunomodulation, we measured the number of CD11c-positive cells, expression of CCRcells present in the kidney mesenchyme increased after IRI. Compared with the sham+I/R in the sham+I/R kidneys ( Fig. 2C-I ). The results showed that even I/R or IPC+I/R had no effect on leukocyte populations ( Fig. 4A and B) . DC percentages decreased in splenocytes from I/Rtreated mice. However, the percentage of DCs increased from IPC+IR mice compared with that in sham+I/R mice ( Fig. 4C and D) . By contrast, the percentage of DCs expressing the mature markers MHC-II and CD80 + was lower in the spleen from IPC+IR animals than sham+I/R animals ( Fig. 4E and F) . These results suggest that renal IPC induces peripheral immune tolerance by increasing tolerogenic DCs and inhibiting DC maturation.
Delayed Ischemic Preconditioning Suppressed Renal Immune Reaction by Inhibiting DC Maturation
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The A2AR Antagonist SCH58261 Inhibited IPC-induced Immune Tolerance and Was
Since activation of A2AR is critical in generating tolerogenic DCs [13], we injected different doses of the A2AR antagonist SCH58261 (1, 2, and 5 mg/kg body weight) to stimulate after IPC and 20 min before I/R. As expected, injection of SCH58261 at 4 days after IPC increased DC maturation in both the kidney and the spleen (Fig. 5 and 6 ). The antiCD11c-positive cells and the extent of CCR7 expression were notably increased by SCH58261 The markedly increased preconditioned ischemic kidneys showed partial reversal, suggesting that the ischemic preconditioning might be partially mediated by DCs (Fig. 7) . Systemic improvements in DC maturation before I/R were associated with partial loss IPC on kidney function and histology. The decreased serum creatinine level and tubular damage observed in preconditioned ischemic kidneys was partially reversed by SCH58261 injection following IPC (Fig.  8) .
Discussion
In the present study, we demonstrated the following: . Accumulating evidence has demonstrated the pivotal role of DCs in determining both renal tissue injury and subsequent reparative progresses, especially in renal IRI. However, the effect of DCs on IRI is disputed. It was reported that depletion of macrophages and dendritic cells by injection of liposome encapsulated clodronate is protective against renal IRI, however, selective depletion of CD11c + DCs by injection of DT in CD11c-DTR transgenic mice failed to protect against IRI [32] . In the same CD11c-DTR transgenic mice model, others reported that DT treatment prior to IRI is protective, suggesting that DCs actively contribute to the early innate injurious response in kidney IRI [33] . Macrophage/dendritic cell depletion during the recovery phase increased functional and histologic injury and delayed regeneration, indicating that macrophages/dendritic cells are important to the mechanism mediating renal tubule epithelial regeneration after IRI [34] . Our present research indicated that renal CD11c of the sham+ IR group. Our results implied that the DC-T cell interactions play crucial roles in the renal protective effect of IPC, however, the underlying mechanism needs to be further assessed.
provides local protection but also protects remote organs, suggesting that the preconditioning effect might also be systemically mediated [22] . Another study reported that circulating immune cells responding to an initial ischemic event could mediate decreased tissue injury after a second ischemic event [57] . In our present study, we found a higher percentage of splenic CD11c + /F4/80 -cells with less surface expression of activation molecules at the initial renal ischemic event on day 5. More importantly, we observed that the alterations of splenocytes observed in renal IPC day 5 were reversed by systemically inhibiting maturation 
Conclusion
In summary, we provided evidence that renal IPC induced systemic and local immune tolerance by mediating the maturation status of the CD11c 
